Baxter International to price senior notes due 2021, 2026, 2046

By Lisa Kerner

Charlotte, N.C., Aug. 10 – Baxter International Inc. plans to price three series of senior notes (Baa2//BBB+) due 2021, 2026 and 2046, according to a 424B2 filed with the Securities and Exchange Commission.

Goldman Sachs & Co., BofA Merrill Lynch and Citigroup Global Markets Inc. are the bookrunners.

Proceeds will be used to redeem certain of the company’s outstanding senior notes, including its 1.85% senior notes due January 2017, 1.85% senior notes due June 2018, 5.375% senior notes due June 2018, 4.5% senior notes due August 2019, 4.25% senior notes due March 2020 and 3.2% senior notes due June 2023.

Remaining proceeds will be used for general corporate purposes, including the repayment of commercial paper.

Baxter is a medical products and health care company based in Deerfield, Ill.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.